Angiopoietin-2-induced arterial stiffness in CKD

Fan Chi Chang, Wen Chih Chiang, Ming Hsuan Tsai, Yu Hsiang Chou, Szu Yu Pan, Yu Ting Chang, Pei Ying Yeh, Yi Ting Chen, Chih Kang Chiang, Yung Ming Chen, Tzong Shinn Chu, Kwan Dun Wu, Shuei Liong Lin

研究成果: 雜誌貢獻文章同行評審

36 引文 斯高帕斯(Scopus)


Themechanismof vascular calcification in CKDis not understood fully, butmay involve collagen deposition in the arterial wall upon osteo/chondrocytic transformation of vascular smoothmuscle cells (VSMCs). Increased levels of circulating angiopoietin-2 correlate with markers of CKD progression and angiopoietin-2 regulate inflammatory responses, including intercellular and vascular adhesion and recruitment of VSMCs. Here, we investigate the potential role of angiopoietin-2 in the pathogenesis of arterial stiffness associated with CKD. In a cohort of 416 patients with CKD, the plasma level of angiopoietin-2 correlated independently with the severity of arterial stiffness assessed bypulse wave velocity. Inmice subjected to 5/6 subtotal nephrectomyor unilateral ureteral obstruction, plasma levels of angiopoietin-2 also increased. Angiopoietin-2 expression markedly increased in tubular epithelial cells of fibrotic kidneys but decreased in other tissues, including aorta and lung, after 5/6 subtotal nephrectomy. Expression of collagen and profibrotic genes in aortic VSMCs increased inmice after 5/6 subtotal nephrectomy and inmice producing human angiopoietin-2. Angiopoietin-2 stimulated endothelial expression of chemokines and adhesion molecules for monocytes, increased Ly6Clow macrophages in aorta, and increased the expression of the profibrotic cytokine TGF-β1 in aortic endothelial cells and Ly6Clow macrophages. Angiopoietin-2 blockade attenuated expression of monocyte chemokines, profibrotic cytokines, and collagen in aorta of mice after 5/6 subtotal nephrectomy. This study identifies angiopoietin-2 as a link between kidney fibrosis and arterial stiffness. Targeting angiopoietin-2 to attenuate inflammation and collagen expression may provide a novel therapy for cardiovascular disease in CKD.

頁(從 - 到)1198-1209
期刊Journal of the American Society of Nephrology
出版狀態已發佈 - 6月 1 2014

ASJC Scopus subject areas

  • 腎臟病學
  • 醫藥 (全部)


深入研究「Angiopoietin-2-induced arterial stiffness in CKD」主題。共同形成了獨特的指紋。